These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results. Ravanshad M, Mahboudi F, Sabahi F, Bayanolhagh S. Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439 [Abstract] [Full Text] [Related]
23. Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies. Shafran SD, Conway B, Prasad E, Greer J, Vincelette J, Ellis CE, Haase DA, Walmsley SL, Lalonde RG, Cameron DW. Clin Infect Dis; 2002 Mar 01; 34(5):658-61. PubMed ID: 11823955 [Abstract] [Full Text] [Related]
24. Human immunodeficiency virus antibody testing: time for clinicians to use it. deHovitz JA, Landesman SH. N Y State J Med; 1988 May 01; 88(5):217-8. PubMed ID: 3164100 [No Abstract] [Full Text] [Related]
29. Evaluation of immunoglobulin M and G Western blot and ELISA for screening antibodies to Treponema pallidum in blood donors. Wang LN, Li JM. Sex Transm Dis; 2009 Jul 01; 36(7):413-6. PubMed ID: 19387420 [Abstract] [Full Text] [Related]
31. Measurement of antibodies to human immunodeficiency virus: an international collaborative study to evaluate WHO reference sera. Garrett AJ, Seagroatt V, Supran EM, Habermehl KO, Hampl H, Schild GC. Bull World Health Organ; 1988 Jul 01; 66(2):197-202. PubMed ID: 3260829 [Abstract] [Full Text] [Related]
33. Laboratory diagnosis of HIV infection. Shriniwas, Srivastava L, Lal S. J Indian Med Assoc; 1994 Jan 01; 92(1):20-1. PubMed ID: 8207274 [Abstract] [Full Text] [Related]
34. A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24-gp41 as a fusion protein expressed in Escherichia coli. Mahboudi F, Irina NA, Chevalier A, Ghadiri A, Adeli A, Amini-Bavil-Olyaee S, Barkhordari F, Farzamfar B, Alinejad M. J Biotechnol; 2006 Sep 01; 125(2):295-303. PubMed ID: 16647775 [Abstract] [Full Text] [Related]
35. Evaluation of particle agglutination test for detection of HIV-I antibodies. Prakash JV, Khare PM, Haridas V. Indian J Pathol Microbiol; 1993 Apr 01; 36(2):138-42. PubMed ID: 8276477 [Abstract] [Full Text] [Related]
37. Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodies. Lee ML, Kingdon HS, Hooper J, Courter SG, Holst SL, Piszkiewicz D. Clin Ther; 1987 Apr 01; 9(3):300-3. PubMed ID: 3111704 [Abstract] [Full Text] [Related]
38. Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. Horowitz GM, Scott RT, Hankins GD. J Reprod Med; 1991 Nov 01; 36(11):773-8. PubMed ID: 1765954 [Abstract] [Full Text] [Related]
39. Human immunodeficiency virus antibody screening in patients on renal replacement therapy: prevalence of false-positive results. Fassbinder W, Fürsch A, Kühnl P, Schoeppe W. Nephrol Dial Transplant; 1987 Nov 01; 2(4):248-50. PubMed ID: 3118266 [Abstract] [Full Text] [Related]
40. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein. Chiodi F, von Gegerfeldt A, Albert J, Fenyö EM, Gaines H, von Sydow M, Biberfeld G, Parks E, Norrby E. J Med Virol; 1987 Sep 01; 23(1):1-9. PubMed ID: 3500271 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]